Target intelligence / Profile preview

CHN2 antisense RNA 1 (CHN2-AS1)

Target: CHN2-AS1
Molecular classification: Antisense long non-coding RNA, Long non-coding RNA (lncRNA)[1][7][8]

Overview

CHN2 antisense RNA 1 (CHN2-AS1) is an antisense long non-coding RNA gene that is transcribed from the genomic region opposite to the CHN2 (chimerin 2) gene. Antisense lncRNAs can regulate the expression of their "sense" protein-coding genes by binding to complementary RNA sequences, influencing mRNA transcription, stability, or translation, and sometimes by recruiting chromatin modifiers or affecting epigenetic marks[7][8][5][1]. While antisense lncRNAs as a class are increasingly recognized for their roles in gene expression and some have been implicated as therapeutic targets or biomarkers in cancer and other diseases[8][3], there is currently no evidence in scientific literature that CHN2-AS1 itself is a validated therapeutic target, disease biomarker, or interacts with any known drugs[1].

Other names: CHN2-AS1

Biological functions

Regulation of gene expression (likely regulates CHN2 gene or associated pathways via antisense mechanisms, based on known roles of antisense lncRNAs; see [7][8])Epigenetic regulation (by analogy with other antisense lncRNAs)[7]Potential roles in cell signaling or gene silencing (common for this class but *not specifically documented* for CHN2-AS1)[8]

Disease associations

Other (no specific associations with cancer, inflammation, or other diseases currently documented for CHN2-AS1 in available sources)[1]

Beyond the preview

Go deeper on CHN2 antisense RNA 1 (CHN2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHN2 antisense RNA 1 (CHN2-AS1).

Explore the full profile